INNATE PHARMA SA-SPONS ADR
IPHA · NASDAQ
更新于 2026-10-15 08:21:23
$1.43-2.72%
- 今日最高
- $1.46
- 今日最低
- $1.42
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $1.44
- 昨日收盘价
- $1.43
- 成交量
- 9395
- 市值
- $1.45亿
- 本益比（P/E）
- --
- 每股收益（EPS）
- $-0.51
昨日价格区间
$1.42$1.46
52周价格区间
$1.03$2.33
公司概况
- 板块
- 医疗保健
- 行业
- 生物技术
- 子行业
- 生物技术
- 总部
- 117, AVENUE DE LUMINY, 马赛, 法国, 13009
- 国家
- FR
- 上市日期
- 2006-10-31
- 财年截止
- 十二月
- 流通股数
- 9392万
- CIK
- 0001598599
Innate Pharma SA 是一家生物技术公司，在法国及国际范围内发现、开发和销售用于治疗肿瘤适应症的治疗性抗体。公司总部位于法国马赛。
财务指标
营业收入
2026-06-30
$315.69万
2026-03-31
-$207.3万
2025-12-31
-$207.3万
2025-06-30
$486万
营业支出
2026-06-30
$2438.69万
2026-03-31
$4644.5万
2025-12-31
$4644.5万
2025-06-30
$976.7万
净利润
2026-06-30
-$1988.71万
2026-03-31
-$2762.7万
2025-12-31
-$2762.7万
2025-06-30
-$2134.4万
净利润率
2026-06-30
-629.95%
2026-03-31
1.33K%
2025-12-31
1.33K%
2025-06-30
-439.17%
每股收益
2026-06-30
--
2026-03-31
$0.00
2025-12-31
--
2025-06-30
$-0.29
息税折旧摊销前利润
2026-06-30
-$2123.82万
2026-03-31
-$3070.5万
2025-12-31
-$3070.5万
2025-06-30
-$2472.4万
有效税率
2026-06-30
11.49%
2026-03-31
10.75%
2025-12-31
10.75%
2025-06-30
--
| 项目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|---|
| 营业收入 | $315.69万 | -$207.3万 | -$207.3万 | $486万 |
| 营业支出 | $2438.69万 | $4644.5万 | $4644.5万 | $976.7万 |
| 净利润 | -$1988.71万 | -$2762.7万 | -$2762.7万 | -$2134.4万 |
| 净利润率 | -629.95% | 1.33K% | 1.33K% | -439.17% |
| 每股收益 | -- | $0.00 | -- | $-0.29 |
| 息税折旧摊销前利润 | -$2123.82万 | -$3070.5万 | -$3070.5万 | -$2472.4万 |
| 有效税率 | 11.49% | 10.75% | 10.75% | -- |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。